149 related articles for article (PubMed ID: 37259217)
1. MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53.
Wang YS; Yin JZ; Shi XQ; Zhao XW; Li B; Yang MH
Anticancer Agents Med Chem; 2023; 23(16):1829-1837. PubMed ID: 37259217
[TBL] [Abstract][Full Text] [Related]
2. Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer.
Yang MH; Li B; Chang KJ
Mol Biol Rep; 2022 Mar; 49(3):2245-2253. PubMed ID: 35028858
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells.
Pettersson HM; Pietras A; Munksgaard Persson M; Karlsson J; Johansson L; Shoshan MC; PĂ„hlman S
Mol Cancer Ther; 2009 Jan; 8(1):160-70. PubMed ID: 19139125
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction.
Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
Cancer Biol Ther; 2007 Apr; 6(4):580-6. PubMed ID: 17374990
[TBL] [Abstract][Full Text] [Related]
5. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
Yang MH; Chang KJ; Li B; Chen WS
Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
[TBL] [Abstract][Full Text] [Related]
6. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
Li H; Zhu X; Zhang Y; Xiang J; Chen H
J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237
[TBL] [Abstract][Full Text] [Related]
9. [Toxicity of arsenic trioxide to human lung adenocarcinoma cell line SPCA1 and its mechanism].
Wei L; Wang XW; Zuo WS
Ai Zheng; 2004 Dec; 23(12):1633-8. PubMed ID: 15601551
[TBL] [Abstract][Full Text] [Related]
10. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
Shao QS; Ye ZY; Ling ZQ; Ke JJ
World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253
[TBL] [Abstract][Full Text] [Related]
12. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer.
Deng ZT; Liang SF; Huang GK; Wang YQ; Tu XY; Zhang YN; Li S; Liu T; Cheng BB
J Integr Med; 2024 May; 22(3):295-302. PubMed ID: 38599914
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Bcl-2 partly inhibits apoptosis of human cervical cancer SiHa cells induced by arsenic trioxide.
Deng Y; Lin C; Zheng J; Fu M; Liang X; Chen J; Xiao P; Wu M
Chin Med J (Engl); 2000 Jan; 113(1):84-8. PubMed ID: 11775218
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.
Zhang XH; Feng R; Lv M; Jiang Q; Zhu HH; Qing YZ; Bao JL; Huang XJ; Zheng XL
Leuk Res; 2013 Dec; 37(12):1719-25. PubMed ID: 24211095
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.
Jadhav V; Ray P; Sachdeva G; Bhatt P
Life Sci; 2016 Mar; 148():41-52. PubMed ID: 26883975
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells.
Sun Y; Wang C; Wang L; Dai Z; Yang K
Cell Mol Biol Lett; 2018; 23():13. PubMed ID: 29610575
[TBL] [Abstract][Full Text] [Related]
20. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]